I-Flow Signs Deal With Brazilian Firm
- Share via
IRVINE — I-Flow Corp. is planning its first entry into the Brazilian market. The company, which develops and markets ambulatory infusion systems, said Thursday it has signed a five-year distribution agreement with one of Brazil’s largest pharmaceutical companies, Laboratorio Biosintetica Ltd. of Sao Paulo.
Laboratorio Biosintetica will distribute I-Flow’s Paragon and Band-It syringe delivery products under terms of the agreement. The company generates revenue of more than $70 million in revenue a year.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
